CIBC Asset Management Inc Has $6.46 Million Position in Colgate-Palmolive (CL)

Share on StockTwits

CIBC Asset Management Inc increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 0.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,546 shares of the company’s stock after buying an additional 895 shares during the quarter. CIBC Asset Management Inc’s holdings in Colgate-Palmolive were worth $6,464,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CL. IFM Investors Pty Ltd lifted its position in shares of Colgate-Palmolive by 42.9% during the 2nd quarter. IFM Investors Pty Ltd now owns 37,356 shares of the company’s stock worth $2,421,000 after buying an additional 11,208 shares during the period. Fisher Asset Management LLC lifted its position in shares of Colgate-Palmolive by 7.4% during the 2nd quarter. Fisher Asset Management LLC now owns 728,409 shares of the company’s stock worth $47,208,000 after buying an additional 49,918 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Colgate-Palmolive by 16.5% during the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 14,819 shares of the company’s stock worth $960,000 after buying an additional 2,100 shares during the period. State of Alaska Department of Revenue lifted its position in shares of Colgate-Palmolive by 29.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 248,529 shares of the company’s stock worth $16,104,000 after buying an additional 55,960 shares during the period. Finally, Private Asset Management Inc. lifted its position in shares of Colgate-Palmolive by 1.6% during the 2nd quarter. Private Asset Management Inc. now owns 129,607 shares of the company’s stock worth $9,290,000 after buying an additional 2,099 shares during the period. Institutional investors and hedge funds own 75.08% of the company’s stock.

Several equities analysts recently commented on the company. Argus restated a “buy” rating and set a $75.00 target price (up previously from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Zacks Investment Research upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Atlantic Securities began coverage on Colgate-Palmolive in a research report on Thursday, September 20th. They issued a “neutral” rating and a $71.00 price objective for the company. ValuEngine upgraded Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Finally, Wells Fargo & Co reiterated a “hold” rating and issued a $64.00 price objective on shares of Colgate-Palmolive in a research report on Friday, July 27th. Four equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $68.06.

In other news, CFO Henning I. Jakobsen sold 1,015 shares of the business’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $68,055.75. Following the completion of the sale, the chief financial officer now owns 36,193 shares in the company, valued at $2,426,740.65. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Vice Chairman Dennis J. Hickey sold 120,000 shares of the business’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $65.72, for a total value of $7,886,400.00. Following the sale, the insider now owns 202,414 shares of the company’s stock, valued at approximately $13,302,648.08. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 169,585 shares of company stock valued at $11,132,140. 1.02% of the stock is currently owned by corporate insiders.

Shares of CL opened at $60.51 on Wednesday. The company has a quick ratio of 0.77, a current ratio of 1.11 and a debt-to-equity ratio of 64.85. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $77.91. The firm has a market capitalization of $52.29 billion, a price-to-earnings ratio of 20.23, a price-to-earnings-growth ratio of 2.96 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 26th. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The firm had revenue of $3.85 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the previous year, the company posted $0.73 EPS. The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive will post 2.96 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 15th. Stockholders of record on Friday, October 19th will be given a dividend of $0.42 per share. The ex-dividend date is Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.78%. Colgate-Palmolive’s payout ratio is currently 58.54%.

WARNING: “CIBC Asset Management Inc Has $6.46 Million Position in Colgate-Palmolive (CL)” was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://weekherald.com/2018/11/07/cibc-asset-management-inc-has-6-46-million-position-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Featured Story: What is the NASDAQ?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply